Sharecast News
25 Nov, 2021 11:36 25 Nov, 2021 11:36

Genincode moving towards 'a number of important milestones'

Predictive genetics company Genincode said on Thursday that it was now moving towards "a number of important milestones" which will drive its growth and profile over the coming years.

Genincode stated these milestones were expected to accelerate its commercial programme to lift the standard of care for cardiovascular disease by enabling "more precise patient diagnosis" and "risk stratification" to improve preventative care.

The AIM-listed firm also highlighted that it was still preparing for the US launch of its Cardio inCode product in 2022.

Chief executive Matthew Walls said: "Since admission in July, we have made solid progress in delivering the key milestones set out in our business plan.

"The business is developing swiftly and we are increasing our investment in key resources and expertise to take advantage of growth opportunities opening to us and strengthening our Board to include a greater US market presence, awareness, and expertise to reflect our long-term goals."

As of 1135 GMT, Genincode shares were up 5.26% at 40.0p.


News Source: © 2021 Web Financial Group (UK) Limited. All rights reserved and terms of use apply.

Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.

 

Important Legal Notice about News Sources

Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news articles and we may not share the views of the author or publisher.

We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.